BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2665657)

  • 1. Invasive Haemophilus influenzae infections in Germany: impact of non-type b serotypes in the post-vaccine era.
    Kalies H; Siedler A; Gröndahl B; Grote V; Milde-Busch A; von Kries R
    BMC Infect Dis; 2009 Apr; 9():45. PubMed ID: 19379490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-benefit analysis of a Haemophilus influenzae type b meningitis prevention programme in The Philippines.
    Limcangco MR; Armour CL; Salole EG; Taylor SJ
    Pharmacoeconomics; 2001; 19(4):391-400. PubMed ID: 11383755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody persistence after accelerated immunisation against Haemophilus influenzae type b.
    Booy R; Hodgson S; Griffiths H; Chapel HM; Moxon ER
    BMJ; 1993 Apr; 306(6883):971-2. PubMed ID: 8490473
    [No Abstract]   [Full Text] [Related]  

  • 4. Paediatrics--Part II.
    Priestley BL; Harrison CJ; Gerrard MP; Gibson A
    Postgrad Med J; 1993 Apr; 69(810):268-81. PubMed ID: 8321790
    [No Abstract]   [Full Text] [Related]  

  • 5. Childhood immunisation in the new decade.
    Rudd PT
    BMJ; 1991 Mar; 302(6775):481-2. PubMed ID: 2012839
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule.
    Booy R; Taylor SA; Dobson SR; Isaacs D; Sleight G; Aitken S; Griffiths H; Chapel H; Mayon-White RT; Macfarlane JA
    Arch Dis Child; 1992 Apr; 67(4):475-8. PubMed ID: 1580674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious diseases and AIDS.
    Welsby PD
    Postgrad Med J; 1992 Jun; 68(800):415-33. PubMed ID: 1437921
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
    Mäkelä PH; Eskola J; Peltola H; Takala AK; Käyhty H
    Pediatrics; 1990 Apr; 85(4 Pt 2):651-3. PubMed ID: 2179855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
    Sood SK; Daum RS
    Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom.
    Tudor-Williams G; Frankland J; Isaacs D; Mayon-White RT; MacFarlane JA; Rees DG; Moxon ER
    Arch Dis Child; 1989 Apr; 64(4):520-4. PubMed ID: 2665657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine.
    Eskola J; Olander RM; Hovi T; Litmanen L; Peltola S; Käyhty H
    Lancet; 1996 Dec 21-28; 348(9043):1688-92. PubMed ID: 8973430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA; Meschievitz CK; Ballanco GA; Daum RS
    Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
    Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
    Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharide-protein conjugate vaccine.
    Anderson P; Pichichero M; Edwards K; Porch CR; Insel R
    J Pediatr; 1987 Nov; 111(5):644-50. PubMed ID: 3499499
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.